Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-08 Purchase | 2024-10-10 4:15 pm | Tharimmune Inc. | THAR | MILBY RANDY CEO | 2,500 | $2.0884 | $5,221 | 12,934 (Direct) | View |
| 2023-12-15 Purchase | 2023-12-18 10:04 am | Tharimmune Inc. | THAR | MILBY RANDY CEO | 29,000 | $0.503 | $14,587 | 156,517 (Direct) | View |
| 2023-11-30 Purchase | 2023-12-04 4:15 pm | Tharimmune Inc. | THAR | MILBY RANDY CEO | 10,000 | $1 | $10,000 | 127,517 (Direct) | View |
| 2022-06-17 Purchase | 2022-06-21 4:15 pm | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner | 500 | $0.7799 | $390 | 2,937,940 (Direct) | View |
| 2022-06-06 Purchase | 2022-06-07 4:15 pm | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 1,000 | $0.68846 | $688 | 2,938,540 (Direct) | View |
| 2022-06-01 Purchase | 2022-06-02 4:15 pm | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 1 | $0.94 | $1 | 2,937,540 (Direct) | View |
| 2022-05-25 Purchase | 2022-05-25 5:28 pm | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 1,000 | $0.786 | $786 | 2,937,539 (Direct) | View |
| 2022-05-20 Purchase | 2022-05-23 4:15 pm | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 1,000 | $0.91825 | $918 | 2,936,539 (Direct) | View |
| 2022-05-19 Purchase | 2022-05-19 4:59 pm | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 1,000 | $0.90765 | $908 | 2,935,539 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-09 Option Award | 2024-08-12 5:17 pm | N/A 2034-08-09 | Tharimmune Inc. | THAR | MILBY RANDY CEO | 57,707 | $0 | 57,707 (Direct) | View |
| 2023-01-01 Option Award(A) | 2023-03-13 4:17 pm | 2023-01-01 2033-01-01 | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner | 515,127 | $0 | 515,127 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 5:43 pm | 2023-01-01 2033-01-01 | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner | 621,795 | $0 | 621,795 (Direct) | View |
| 2022-04-18 Exercise | 2022-04-19 08:05 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 7,575 | $0.314 | 2,944,009 (Direct) | View |
| 2022-04-18 Exercise | 2022-04-19 08:05 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 217,801 | $0.079 | 2,944,009 (Direct) | View |
| 2022-04-18 Exercise | 2022-04-19 08:05 am | 2020-02-29 2030-02-28 | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 240,526 | $0 | 2,944,009 (Direct) | View |
Ownership(A) | 2022-04-19 08:00 am | N/A 2023-06-20 | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 0 | $0 | 117,986 (Direct) | View |
| 2022-01-14 Conversion | 2022-01-20 09:26 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 276,289 | $3.2 | 3,451,588 (Direct) | View |
| 2022-01-14 Conversion | 2022-01-20 09:26 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 864,490 | $0 | 3,451,588 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-20 09:26 am | N/A 2032-01-14 | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 757,575 | $0 | 3,451,588 (Direct) | View |
| 2022-01-14 Conversion | 2022-01-20 09:25 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 260,674 | $3.2 | 2,417,724 (Direct) | View |
| 2022-01-14 Conversion | 2022-01-20 09:25 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 793,702 | $0 | 2,417,724 (Direct) | View |
| 2022-01-14 Conversion | 2022-01-20 09:23 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 384,325 | $3.2 | 2,157,050 (Direct) | View |
| 2022-01-14 Conversion | 2022-01-20 09:23 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 1,146,126 | $0 | 2,157,050 (Direct) | View |
Ownership(A) | 2022-01-20 09:21 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer 10% Owner | 0 | $0 | 1,772,725 (Direct) | View |
Ownership | 2022-01-12 09:26 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2022-01-12 09:24 am | N/A N/A | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2022-01-12 09:22 am | N/A 2023-06-20 | Hillstream BioPharma Inc. | HILS | MILBY RANDY Chief Executive Officer | 0 | $0 | 621,759 (Direct) | View |